CoSign Digital Signatures Keep Clinical Operations Rolling at Westat CRO
“With CoSign, we’ve managed to expedite the approval and distribution of standard operating procedures, as well as the approval and implementation of systems from the Development team, and more”.“The idea to implement CoSign grew largely out of our desire to link the people that are signing off on regulatory documents but are physically disconnected,” explains Jennifer Yunis, Senior Quality Assurance Associate, Westat. “Further, it was crucial for us to employ a solution that would enable regulatory compliance, while also driving significant time and cost savings.”
With CoSign digital signatures for clinical operations, Westat’s CRAs and other Clinical Trials professionals can quickly and compliantly sign off on site monitoring reports, IRB forms, training requirements forms and more. Employees in other sectors are also using CoSign to digitally sign project plan approvals, software development lifecycle documents, internal audit reports, archiving forms, project plan approvals and even expense reports. Due to CoSign’s seamless integration with all major document formats, these users are able to digitally sign Microsoft® Word, Adobe® PDF, and other document types they most commonly use from within the applications themselves.
“With CoSign, we’ve managed to expedite the approval and distribution of standard operating procedures, as well as the approval and implementation of systems from the Development team, and more,” says Yunis. “Processes that used to take us weeks to get approved or completed now get completed in the course of half-an-hour or an hour, depending on how long it takes people to look at their email.”
“Westat pursued an initial Proof of Concept using CoSign for digital signatures and, once deemed successful and valuable, has progressively deployed the technology throughout their enterprise,” said Rodd Schlerf, FDA and USDA Markets Manager, ARX. “CoSign has become the de facto standard in clinical research organizations of all sizes ranging from the largest CROs in the world as well as mid-sized and niche organizations.”
Westat is an employee-owned corporation providing research services to agencies of the U.S. Government, as well as businesses, foundations, and state and local governments. In addition to capabilities as a leading statistical survey research organization, Westat has developed skills and experience in custom research and program evaluation studies across a broad range of subject areas. Westat also has the technical expertise in survey and analytical methods, computer systems technology, biomedical science, and clinical trials to sustain a leadership position in all their research endeavors.
For more information please visit http://www.westat.com.
About CoSign Digital Signatures in Life Sciences
ARX (Algorithmic Research) is a global provider of cost-efficient digital signature solutions for industries such as life sciences, healthcare, government, engineering, and energy. ARX’s CoSign digital signature solution fully automates approval workflows, allowing organizations to go paperless, expedite business processes, and eliminate the expenses and time allocations that paper-based signatures require. CoSign is the most widely-deployed digital signature solution in the Life Sciences industry, employed by over 10,000 FDA-regulated organizations including 5 of the top 10 Pharmaceuticals and 6 of the top 10 CROs. Via its standards-based underpinnings, the CoSign digital signature solution ensures signer intent, document integrity and compliance, while significantly streamlining business processes. CoSign creates a truly collaborative environment for the multiple parties involved in the Life Sciences ecosystem, enabling trust of electronic documentation spanning geographic locations and across organizations. Watch a Digital Signatures for Life Sciences video to learn how life sciences organizations can benefit from CoSign.
CoSign is a registered trademark of Algorithmic Research, Ltd. All other trade names and trademarks are the property of their respective holders.